BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37454712)

  • 1. Elevation of NAD
    Metcalfe M; David BT; Langley BC; Hill CE
    Exp Neurol; 2023 Oct; 368():114479. PubMed ID: 37454712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide Riboside Regulates Chemotaxis to Decrease Inflammation and Ameliorate Functional Recovery Following Spinal Cord Injury in Mice.
    Li Y; Zhang C; Li Z; Bai F; Jing Y; Ke H; Zhang S; Yan Y; Yu Y
    Curr Issues Mol Biol; 2024 Feb; 46(2):1291-1307. PubMed ID: 38392200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease.
    Ryu WI; Shen M; Lee Y; Healy RA; Bormann MK; Cohen BM; Sonntag KC
    Aging Cell; 2022 Jul; 21(7):e13658. PubMed ID: 35730144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells.
    Kropotov A; Kulikova V; Solovjeva L; Yakimov A; Nerinovski K; Svetlova M; Sudnitsyna J; Plusnina A; Antipova M; Khodorkovskiy M; Migaud ME; Gambaryan S; Ziegler M; Nikiforov A
    J Biol Chem; 2022 Dec; 298(12):102615. PubMed ID: 36265580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma.
    Goulart Nacácio E Silva S; Occhiutto ML; Costa VP
    Eur J Ophthalmol; 2023 Sep; 33(5):1801-1815. PubMed ID: 36916064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration.
    Mukherjee S; Chellappa K; Moffitt A; Ndungu J; Dellinger RW; Davis JG; Agarwal B; Baur JA
    Hepatology; 2017 Feb; 65(2):616-630. PubMed ID: 27809334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing NAD
    Cercillieux A; Ciarlo E; Canto C
    Cell Mol Life Sci; 2022 Aug; 79(8):463. PubMed ID: 35918544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
    Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
    Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-energy extracorporeal shock wave therapy for promotion of vascular endothelial growth factor expression and angiogenesis and improvement of locomotor and sensory functions after spinal cord injury.
    Yahata K; Kanno H; Ozawa H; Yamaya S; Tateda S; Ito K; Shimokawa H; Itoi E
    J Neurosurg Spine; 2016 Dec; 25(6):745-755. PubMed ID: 27367940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells.
    Kropotov A; Kulikova V; Nerinovski K; Yakimov A; Svetlova M; Solovjeva L; Sudnitsyna J; Migaud ME; Khodorkovskiy M; Ziegler M; Nikiforov A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
    Morevati M; Egstrand S; Nordholm A; Mace ML; Andersen CB; Salmani R; Olgaard K; Lewin E
    PLoS One; 2021; 16(6):e0252554. PubMed ID: 34061900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury.
    Yamaya S; Ozawa H; Kanno H; Kishimoto KN; Sekiguchi A; Tateda S; Yahata K; Ito K; Shimokawa H; Itoi E
    J Neurosurg; 2014 Dec; 121(6):1514-25. PubMed ID: 25280090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Treatment With Nicotinamide Riboside Is Protective in a Mouse Model of Light-Induced Retinal Degeneration.
    Zhang X; Henneman NF; Girardot PE; Sellers JT; Chrenek MA; Li Y; Wang J; Brenner C; Nickerson JM; Boatright JH
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):47. PubMed ID: 32852543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
    Kahn B; Borrelli M; Libby T
    J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
    Brakedal B; Dölle C; Riemer F; Ma Y; Nido GS; Skeie GO; Craven AR; Schwarzlmüller T; Brekke N; Diab J; Sverkeli L; Skjeie V; Varhaug K; Tysnes OB; Peng S; Haugarvoll K; Ziegler M; Grüner R; Eidelberg D; Tzoulis C
    Cell Metab; 2022 Mar; 34(3):396-407.e6. PubMed ID: 35235774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats.
    Hamity MV; White SR; Walder RY; Schmidt MS; Brenner C; Hammond DL
    Pain; 2017 May; 158(5):962-972. PubMed ID: 28346814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health.
    Alegre GFS; Pastore GM
    Curr Nutr Rep; 2023 Sep; 12(3):445-464. PubMed ID: 37273100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside.
    Xiao Y; Wang Q; Zhang H; Nederlof R; Bakker D; Siadari BA; Wesselink MW; Preckel B; Weber NC; Hollmann MW; Schomakers BV; van Weeghel M; Zuurbier CJ
    Basic Res Cardiol; 2024 Jun; 119(3):403-418. PubMed ID: 38528175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal Protection by Nicotinamide Riboside via SIRT1-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration.
    Kitaoka Y; Sase K; Tsukahara C; Fujita N; Arizono I; Takagi H
    Mol Neurobiol; 2020 Dec; 57(12):4952-4960. PubMed ID: 32820458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term nicotinamide riboside treatment improves muscle quality and function in mice and increases cellular energetics and differentiating capacity of myogenic progenitors.
    Seldeen KL; Shahini A; Thiyagarajan R; Redae Y; Leiker M; Rajabian N; Dynka A; Andreadis ST; Troen BR
    Nutrition; 2021; 87-88():111189. PubMed ID: 33744645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.